monocrotaline has been researched along with Body Weight in 86 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (24.42) | 18.7374 |
1990's | 22 (25.58) | 18.2507 |
2000's | 27 (31.40) | 29.6817 |
2010's | 14 (16.28) | 24.3611 |
2020's | 2 (2.33) | 2.80 |
Authors | Studies |
---|---|
Kaisho, M; Okada, M; Otani, K; Sugiyama, A; Yamawaki, H | 1 |
Hu, J; Liu, S; Liu, W; Lu, S; Wang, Y; Wang, Z; Zeng, X | 1 |
Ahn, B; Al-Rajhi, M; Empinado, HM; Ferreira, LF; Judge, AR | 1 |
Chen, IJ; Dai, ZK; Huang, CH; Liu, CP; Wu, BN; Wu, JR; Yeh, JL | 1 |
Hamada, S; Hattori, A; Kawabata, M; Nakadate, K; Nakagawa, M; Takasawa, H; Takashima, R; Wako, Y; Yasunaga, K | 1 |
Deie, M; Fujino, H; Fujita, N; Sakamoto, H; Takegaki, J | 1 |
Cho, MS; Hong, YM; Kim, KC; Lee, H; Suh, SH | 1 |
Bardou, M; Dumas, M; Goirand, F; Guerard, P; Lirussi, F; Rakotoniaina, Z; Rochette, L | 2 |
Booth, FW; Lees, SJ; Steffen, BT | 1 |
Amano, S; Arai, Y; Chandra, BI; Hirose, K; Ikeda, T; Kimura, Y; Komeda, M; Kushibiki, T; Marui, A; Sakaguchi, H; Tabata, Y; Yuang, H | 1 |
Hasegawa, Y; Inaji, H; Matsumura, Y; Nakagawa, E; Nishida, M; Ohkita, M; Tanida, I | 1 |
Benassi, JC; Górniak, SL; Haraguchi, M; Hueza, IM; Raspantini, LE; Raspantini, PC; Sa, LR | 1 |
Abe, Y; Daicho, T; Marunouchi, T; Ohara, M; Takano, S; Takeo, S; Tanonaka, K; Yagi, T | 1 |
Hara, Y; Harada, T; Kikuzuki, R; Okada, M; Yamawaki, H | 1 |
Araujo, AS; Belló-Klein, A; Caron-Lienert, R; Llesuy, S; Ludke, AR; Mosele, F; Partata, W; Ribeiro, MF; Singal, P | 1 |
Huang, DD; Luo, D; Luo, W; Ou, JS; Ou, ZJ; Wang, ZP; Wei, W; Zhang, X | 1 |
He, B; Pu, J; Shen, J; Shen, L | 1 |
Beliën, JA; Grunberg, K; Hadi, AM; Meijer, GA; Mouchaers, KT; Schalij, I; van der Laarse, WJ; Vonk-Noordegraaf, A | 1 |
Dai, G; Ma, P; Pei, Y; Wang, X; Xu, Q; Yan, L; Zhang, W; Zhang, X; Zheng, P | 1 |
Beretta, L; Fumagalli, F; Latini, R; Masson, S; Santaniello, A; Scorza, R; Zambelli, V | 1 |
Araújo, AS; Becker, CU; Belló-Klein, A; Campos, C; Colombo, R; Fernandes, TR; Siqueira, R | 1 |
Chen, KH; Chen, MJ; Lai, YL | 1 |
Cho, MS; Hong, YM; Kim, BK; Kim, KC; Son, JS | 1 |
Goto, J; Ishikawa, K; Kawamura, K; Maruyama, Y; Matumoto, H; Sugawara, D; Watanabe, Y | 1 |
Brindley, DN; DeAlmeida, J; Mitani, Y; Mutlu, A; Rabinovitch, M; Russell, JC | 1 |
Berry, GJ; Faul, JL; Kao, PN; Nishimura, T; Pearl, RG; Qiu, D; Vaszar, LT | 1 |
Chen, MJ; Lai, YL | 1 |
Campbell, AI; Ng, D; Robb, M; Stewart, DJ; Zhao, YD | 1 |
Brodde, OE; Hartmann, O; Hasenfuss, G; Kögler, H; Leineweber, K; Nguyen van, P; Schott, P | 1 |
Angelini, A; Dalla Libera, L; Danieli Betto, D; Della Barbera, M; Germinario, E; Gobbo, V; Ravara, B; Vescovo, G; Volterrani, M | 1 |
Ahn, BH; Cho, HG; Lee, HA; Lee, WJ; Lee, YM; Park, HK; Yang, EK | 1 |
Bongrani, S; Cargnioni, A; Ferrari, R; Gitti, GL; Pasini, E; Pastore, F; Razzetti, R | 1 |
Brunner, F; Stessel, H | 1 |
Eshiro, K; Matsumura, Y; Nishida, M; Okada, Y; Takaoka, M | 1 |
Conner, WE; Davenport, JW | 1 |
Jackson, EK; Mady, HH; Melhem, MF; Salah, EM; Tofovic, SP | 1 |
Ku, DD; Sun, X | 1 |
Ikeda, M; Ito, K; Ito, KM; Kato, T; Nasu, T; Sonoda, H | 1 |
Chang, LT; Chiang, CH; Lee, FY; Sheu, JJ; Sun, CK; Wu, CJ; Yip, HK; Youssef, AA | 1 |
Bruner, LH; Hilliker, KS; Roth, RA | 1 |
Hilliker, KS; Roth, RA | 1 |
Molteni, A; Port, CD; Solliday, NH; Ts'ao, CH; Ward, WF | 1 |
Cheeke, PR; Garrett, BJ | 1 |
Burguera, JA; Edds, GT | 1 |
Bell, TG; Hilliker, KS; Roth, RA | 1 |
Jago, MV; Jarrett, RG; Peterson, JE; Reddy, JK | 1 |
Bell, TG; Hilliker, KS; Lorimer, D; Roth, RA | 1 |
Heath, D; King, AP; Smith, P | 1 |
Lai, YL; Zhou, KR | 1 |
Bhatti, T; Cathapermal, S; Chen, MF; Farhat, MY; Iqbal, A; Ramwell, PW | 1 |
Hacker, AD | 1 |
Harada, Y; Inoue, M; Mori, C; Tanaka, O; Watanabe, K | 1 |
Jones, AD; Lamé, MW; Pan, LC; Segall, HJ; Wilson, DW | 1 |
Huxtable, RJ; Yan, CC | 1 |
Imai, S; Kanda, T; Kobayashi, I; Murata, K; Suzuki, T; Takahashi, T | 1 |
Banner, W; Burch, GH; Hammond, EH; Jensen, LR; Pappas, J; Shaddy, RE | 1 |
Agnoletti, L; Bachetti, T; Ceconi, C; Comini, L; Curello, S; Ferrari, R; Gaia, G; Pasini, E; Pepi, P | 1 |
Bittner, HB; Chen, EP; Davis, RD; Van Trigt, P | 1 |
Brown, L; Dagger, A; Miller, J; Sernia, C | 1 |
Ambrosio, GB; Bernocchi, P; Carraro, U; Ceconi, C; Ferrari, R; Libera, LD; Vescovo, G | 1 |
Adachi, H; Kodama, K | 1 |
Gout, B; Khandoudi, N; Le Dantec, C; Quiniou, MJ; Saïag, B | 1 |
Hori, M; Karaki, H; Nakazawa, H; Ozaki, H | 1 |
Ambrosio, GB; Libera, LD; Sandri, M; Vescovo, G; Zennaro, R | 1 |
Brodde, OE; Gerbershagen, HP; Giessler, C; Heinroth-Hoffmann, I; Leineweber, K; Pönicke, K; Seyfarth, T | 1 |
Chen, MJ; Chiang, LY; Lai, YL | 1 |
Górniak, SL; Guerra, JL; Medeiros, RM; Soto-Blanco, B | 1 |
Cassis, LA; Fitz, R; Gillespie, MN; Painter, DJ; Rippetoe, PE; Soltis, EE | 1 |
Roth, RA; Schultze, AE; Wagner, JG | 1 |
Roth, RA; Schultze, AE; Wagner, JG; White, SM | 1 |
Deyo, JA; Kerkvliet, NI | 1 |
Ganey, PE; Reindel, JF; Roth, RA; Slocombe, RF; Wagner, JG | 1 |
Hayashi, K; Ito, K; Murakami, T; Nakashima, T | 1 |
Gillespie, MN; Olson, JW; Orlinska, U | 1 |
Roth, RA; Wagner, JG; White, SM | 1 |
Fink, GD; Ganey, PE; Roth, RA | 1 |
Dunne, M; Molteni, A; Solliday, NH; Ts'ao, CH; Ward, WF | 1 |
Molteni, A; Solliday, NH; Ts'ao, CH; Ward, WF | 1 |
Molteni, A; Solliday, N; Ts'ao, C; Ward, W | 1 |
Braun, RC; Dickinson, JO | 1 |
Ganey, PE; Roth, RA | 1 |
Banner, W; Huxtable, RJ; Shubat, PJ | 1 |
Rabinovitch, M; Rosenberg, HC | 1 |
Langleben, D; Reid, LM | 1 |
Bruner, LH; Bull, RW; Roth, RA | 1 |
86 other study(ies) available for monocrotaline and Body Weight
Article | Year |
---|---|
Decreased Expression of Canstatin in Rat Model of Monocrotaline-Induced Pulmonary Arterial Hypertension: Protective Effect of Canstatin on Right Ventricular Remodeling.
Topics: Animals; Body Weight; Cardiotonic Agents; Collagen Type IV; Drug Evaluation, Preclinical; Enzyme-Linked Immunosorbent Assay; Fibrosis; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy; Kidney; Lung; Male; Monocrotaline; Organ Size; Peptide Fragments; Rats; Rats, Wistar; Recombinant Proteins; Ventricular Remodeling | 2020 |
Sacubitril/valsartan treatment relieved the progression of established pulmonary hypertension in rat model and its mechanism.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Body Weight; Disease Models, Animal; Disease Progression; Drug Combinations; Hypertension, Pulmonary; Hypoxia; Male; Monocrotaline; Rats; Rats, Sprague-Dawley; Tetrazoles; Valsartan | 2021 |
Diaphragm atrophy and contractile dysfunction in a murine model of pulmonary hypertension.
Topics: Animals; Atrophy; Body Weight; Diaphragm; Disease Models, Animal; Eating; Hypertension, Pulmonary; Male; Mice; Mice, Inbred C57BL; Monocrotaline; Muscle Contraction | 2013 |
Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Topics: Animals; Blood Pressure; Body Weight; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Endothelin-1; Guanylate Cyclase; Heart Rate; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; In Vitro Techniques; Male; Monocrotaline; Nitric Oxide Synthase Type III; Piperazines; Piperidines; Pulmonary Artery; Purines; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Sildenafil Citrate; Soluble Guanylyl Cyclase; Sulfonamides; Vasoconstriction; Xanthines | 2014 |
Micronucleus induction in rat liver and bone marrow by acute vs. repeat doses of the genotoxic hepatocarcinogen monocrotaline.
Topics: Administration, Oral; Age Factors; Animals; Body Weight; Bone Marrow; Carcinogens; Chromosome Aberrations; Cooperative Behavior; Dose-Response Relationship, Drug; Drug Administration Schedule; Hepatocytes; Humans; Japan; Leukocytes, Mononuclear; Liver; Male; Micronucleus Tests; Monocrotaline; Organ Specificity; Rats; Rats, Sprague-Dawley; Reticulocytes; Societies, Pharmaceutical | 2015 |
Time course of ubiquitin-proteasome and macroautophagy-lysosome pathways in skeletal muscle in rats with heart failure.
Topics: Animals; Autophagy; Body Weight; Disease Models, Animal; Heart; Heart Failure; Lung; Lysosomes; Male; Monocrotaline; Muscle, Skeletal; Muscular Atrophy; Organ Size; Proteasome Endopeptidase Complex; Rats; Rats, Wistar; Ubiquitin | 2015 |
Modafinil improves monocrotaline-induced pulmonary hypertension rat model.
Topics: Animals; Benzhydryl Compounds; Body Weight; Cyclic AMP; Disease Models, Animal; Endothelin-1; Gene Expression Regulation; Heart Ventricles; Humans; Hypertension, Pulmonary; Intermediate-Conductance Calcium-Activated Potassium Channels; Male; Modafinil; Monocrotaline; Myocytes, Smooth Muscle; Pressure; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Vasoconstriction | 2016 |
Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.
Topics: Acetylcholine; Animals; Atorvastatin; Blotting, Western; Body Weight; Caspase 3; Celecoxib; Cyclooxygenase Inhibitors; Disease Progression; Drug Combinations; Hemodynamics; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Myocardium; Nitric Oxide Synthase Type III; Pulmonary Artery; Pyrazoles; Pyrroles; Rats; Rats, Wistar; Sulfonamides; Survival Analysis; Vasodilator Agents | 2008 |
Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia.
Topics: Animals; Anorexia; Blotting, Western; Body Weight; Cachexia; Eating; Enzyme-Linked Immunosorbent Assay; Gene Expression; Heart Diseases; Male; Monocrotaline; Muscle, Skeletal; Organ Size; Pentoxifylline; Poisons; Rats; Rats, Sprague-Dawley; Receptors, Tumor Necrosis Factor, Type I; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Tumor Necrosis Factor Inhibitors; Ubiquitin; Weight Loss | 2008 |
Novel approach with intratracheal administration of microgelatin hydrogel microspheres incorporating basic fibroblast growth factor for rescue of rats with monocrotaline-induced pulmonary hypertension.
Topics: Animals; Blood Gas Analysis; Body Weight; Disease Progression; Fibroblast Growth Factor 2; Gelatin; Hemodynamics; Hydrogels; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; Microspheres; Monocrotaline; Rats; Rats, Wistar; Trachea | 2008 |
Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
Topics: Animals; Blood Pressure; Body Weight; Endothelin-1; Female; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Monocrotaline; Organ Size; Ovariectomy; Pulmonary Artery; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Substrate Specificity; Time Factors; Ventricular Dysfunction, Right | 2009 |
Low doses of monocrotaline in rats cause diminished bone marrow cellularity and compromised nitric oxide production by peritoneal macrophages.
Topics: Administration, Oral; Animal Structures; Animals; Antibodies; Antibody Formation; Body Weight; Bone Marrow; Bone Marrow Cells; Cell Count; Eating; Hydrogen Peroxide; Hypersensitivity, Delayed; Immunity, Cellular; Immunity, Innate; L-Lactate Dehydrogenase; Lipopolysaccharides; Macrophages, Peritoneal; Male; Monocrotaline; Nitric Oxide; Phagocytosis; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate | 2009 |
Alterations in pharmacological action of the right ventricle of monocrotaline-induced pulmonary hypertensive rats.
Topics: Animals; Body Weight; Cardiotonic Agents; Disease Models, Animal; Electrocardiography; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; In Vitro Techniques; Male; Monocrotaline; Myocardial Contraction; Organ Size; Perfusion; Rats; Rats, Wistar; Ventricular Function, Right | 2009 |
Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Body Weight; Echocardiography; Fibrosis; Histocytochemistry; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Monocrotaline; Myocardium; Organ Size; Rats; Rats, Wistar; Stroke Volume; Systole; Telmisartan; Transforming Growth Factor beta1; Ventricular Remodeling | 2009 |
Modulation of monocrotaline-induced cor pulmonale by grape juice.
Topics: Animals; Antioxidants; Beverages; Body Weight; Disease Models, Animal; Lipid Peroxidation; Lung; Male; Monocrotaline; Nitric Oxide Synthase Type III; Organ Size; Pulmonary Heart Disease; Rats; Rats, Wistar; Ventricular Pressure; Vitis | 2010 |
L-arginine restores endothelial nitric oxide synthase-coupled activity and attenuates monocrotaline-induced pulmonary artery hypertension in rats.
Topics: Animals; Arginine; Blood Pressure; Blotting, Western; Body Weight; HSP90 Heat-Shock Proteins; Hypertension, Pulmonary; Immunoprecipitation; Kaplan-Meier Estimate; Male; Monocrotaline; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Pulmonary Artery; Rats; Rats, Sprague-Dawley | 2010 |
Aspirin attenuates pulmonary arterial hypertension in rats by reducing plasma 5-hydroxytryptamine levels.
Topics: Animals; Aspirin; Blood Pressure; Body Weight; Disease Models, Animal; Heart Rate; Hemodynamics; Hypertension, Pulmonary; Male; Monocrotaline; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Serotonin; Survival Analysis | 2011 |
Rapid quantification of myocardial fibrosis: a new macro-based automated analysis.
Topics: Animals; Automation; Azo Compounds; Body Weight; Electrocardiography; Fibrosis; Hemodynamics; Humans; Hypertension, Pulmonary; Image Processing, Computer-Assisted; Microscopy, Polarization; Monocrotaline; Myocardium; Organ Size; Paraffin Embedding; Rats; Rats, Wistar; Time Factors; Ultrasonography | 2011 |
Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism.
Topics: Amidohydrolases; Animals; Arginine; Biomarkers; Body Weight; Fluorobenzenes; Gene Expression Regulation, Enzymologic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Nitric Oxide Synthase Type III; Organ Size; Protein-Arginine N-Methyltransferases; Proto-Oncogene Proteins c-akt; Pyrimidines; Rats; Rats, Sprague-Dawley; Rosuvastatin Calcium; Signal Transduction; Sulfonamides; Ventricular Dysfunction, Right | 2011 |
Efficacy of aminaftone in a rat model of monocrotaline-induced pulmonary hypertension.
Topics: 4-Aminobenzoic Acid; Animals; Body Weight; Cardiomegaly; Disease Models, Animal; Endothelin-1; Hemodynamics; Hypertension, Pulmonary; Male; Monocrotaline; para-Aminobenzoates; Pulmonary Artery; Rats; Rats, Wistar; Survival Analysis | 2011 |
Influence of estrogen on pulmonary arterial hypertension: role of oxidative stress.
Topics: Animals; Blotting, Western; Body Weight; Diestrus; Estradiol; Female; Glutathione; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Monocrotaline; Ovariectomy; Oxidative Stress; Plant Oils; Pulmonary Artery; Rats; Rats, Wistar; Sunflower Oil | 2011 |
Oxygen radicals and substance P in perinatal hypoxia-exaggerated, monocrotaline-induced pulmonary hypertension.
Topics: Animals; Antioxidants; Atmosphere Exposure Chambers; Blood Pressure; Body Weight; Capsaicin; Female; Heart Rate; Humans; Hypertension, Pulmonary; Hypoxia; Male; Monocrotaline; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Reactive Oxygen Species; Sensory System Agents; Substance P | 2012 |
Effect of small hairpin RNA targeting endothelin-converting enzyme-1 in monocrotaline-induced pulmonary hypertensive rats.
Topics: Animals; Aspartic Acid Endopeptidases; Body Weight; Endothelin-Converting Enzymes; Heart Ventricles; Hypertension, Pulmonary; Lentivirus; Lung; Male; Metalloendopeptidases; Monocrotaline; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; RNA, Small Interfering; Survival Rate; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2012 |
Heme oxygenase-1 reduces murine monocrotaline-induced pulmonary inflammatory responses and resultant right ventricular overload.
Topics: Animals; Body Weight; Cardiomegaly; Disease Models, Animal; Enzyme Inhibitors; Heart Ventricles; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Hypertension, Pulmonary; Inflammation; Lung; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Monocrotaline; Myocytes, Cardiac; Rats; Stress, Mechanical; Ventricular Function, Right | 2002 |
Dexfenfluramine protects against pulmonary hypertension in rats.
Topics: Animals; Appetite Depressants; Body Weight; Dexfenfluramine; Eating; Endothelium, Vascular; Female; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Monocrotaline; Myocardium; Nitric Oxide Synthase; Obesity; Organ Size; Pancreatic Elastase; Pulmonary Artery; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Vascular Diseases | 2002 |
Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.
Topics: Animals; Anticholesteremic Agents; Body Weight; Cholesterol; Disease Models, Animal; Gene Expression Regulation; Heart Ventricles; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; Monocrotaline; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Organ Size; Pneumonectomy; Pulmonary Artery; Rats; Rats, Sprague-Dawley; RNA, Messenger; Simvastatin; Treatment Outcome; Tunica Intima | 2002 |
Tachykinin dysfunction attenuates monocrotaline-induced pulmonary hypertension.
Topics: Animals; Blood Pressure; Body Weight; Heart Rate; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Organ Size; Rats; Rats, Wistar; Receptors, Tachykinin; RNA Interference; RNA, Double-Stranded; Substance P; Tachykinins | 2003 |
Protective role of angiopoietin-1 in experimental pulmonary hypertension.
Topics: Angiogenesis Inducing Agents; Angiopoietin-1; Angiopoietin-2; Animals; Apoptosis; Body Weight; Caspase 3; Caspases; Cell Transplantation; Cells, Cultured; Cytoprotection; Genetic Therapy; Hypertension, Pulmonary; Lung; Membrane Glycoproteins; Monocrotaline; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Inbred F344; Receptor Protein-Tyrosine Kinases; Receptor, TIE-2; RNA, Messenger; Transfection; Transgenes; Ventricular Pressure | 2003 |
Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat.
Topics: Actin Cytoskeleton; Adrenergic beta-Agonists; Animals; Biomechanical Phenomena; Body Weight; Calcium; Calcium-Binding Proteins; Calcium-Transporting ATPases; Disease Models, Animal; Down-Regulation; Gene Expression Regulation; Heart Ventricles; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; In Vitro Techniques; Isoproterenol; Male; Monocrotaline; Myocardial Contraction; Norepinephrine; Organ Size; Rats; Rats, Wistar; RNA, Messenger; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Stress, Mechanical | 2003 |
Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure.
Topics: Angiotensin II; Animals; Apoptosis; Body Weight; Cardiac Output, Low; Caspases; Cytochromes c; Human Growth Hormone; In Situ Nick-End Labeling; Insulin-Like Growth Factor I; Isometric Contraction; Male; Monocrotaline; Muscle, Skeletal; Muscular Atrophy; Myosin Heavy Chains; Physical Endurance; Rats; Rats, Sprague-Dawley; Sphingosine; Tumor Necrosis Factor-alpha | 2004 |
Estrogen and enalapril attenuate the development of right ventricular hypertrophy induced by monocrotaline in ovariectomized rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Body Weight; Densitometry; Disease Progression; Enalapril; Endothelin-1; Estrogens; Female; Hypertrophy, Right Ventricular; Male; Microscopy, Electron; Monocrotaline; Ovariectomy; Rats; Rats, Sprague-Dawley; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Sex Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling | 2003 |
Effect of nolomirole on monocrotaline-induced heart failure.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Aldosterone; Animals; Ascitic Fluid; Atrial Natriuretic Factor; Body Weight; Disease Models, Animal; Dopamine Agonists; Drug Evaluation, Preclinical; Esters; Female; Heart Atria; Heart Failure; Heart Ventricles; Hypertrophy, Right Ventricular; Indoles; Monocrotaline; Norepinephrine; Pleural Effusion; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes | 2004 |
Effect of endothelin antagonism on contractility, intracellular calcium regulation and calcium regulatory protein expression in right ventricular hypertrophy of the rat.
Topics: Animals; Blood Pressure; Body Weight; Calcium; Dioxoles; Endothelins; Female; Hypertrophy, Right Ventricular; Monocrotaline; Myocardial Contraction; Organ Size; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum | 2004 |
Roles of endothelin ETA and ETB receptors in the pathogenesis of monocrotaline-induced pulmonary hypertension.
Topics: Administration, Oral; Animals; Atrasentan; Blood Pressure; Body Mass Index; Body Weight; Cardiomegaly; Drug Administration Schedule; Drug Therapy, Combination; Heart; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Injections, Subcutaneous; Intubation, Gastrointestinal; Lung; Male; Monocrotaline; Organ Size; Pulmonary Artery; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Time Factors; Tunica Media; Ventricular Pressure | 2004 |
Dietary alkaloids and the development of androconial organs in Estigmene acrea.
Topics: Animals; Body Weight; Diet; Dose-Response Relationship, Drug; Female; Larva; Male; Molecular Structure; Monocrotaline; Morphogenesis; Moths; Pheromones; Pyrrolizidine Alkaloids; Sexual Behavior, Animal; Social Behavior | 2003 |
Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
Topics: 2-Methoxyestradiol; Animals; Blood Pressure; Body Weight; Cell Proliferation; Disease Progression; Estradiol; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Immunohistochemistry; Lung; Male; Monocrotaline; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Time Factors; Tubulin Modulators | 2005 |
The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
Topics: Acetylcholine; Animals; Apoptosis; Blood Pressure; Blotting, Western; Body Weight; Caspase 3; Disease Progression; Endothelial Cells; Heart Function Tests; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Immunohistochemistry; In Situ Nick-End Labeling; Lung; Male; Monocrotaline; Nitric Oxide Synthase Type III; Nitroprusside; Poisons; Pravastatin; Pulmonary Artery; Rats; Rats, Wistar; Survival; Vasodilator Agents | 2006 |
Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in rats.
Topics: Animals; Blood Pressure; Blotting, Western; Body Weight; Coronary Disease; Endothelium, Vascular; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Nitric Oxide; Organ Size; Poisons; Pyrimidines; Rats; Rats, Sprague-Dawley; Rosuvastatin Calcium; Sulfonamides | 2008 |
Evaluation of olmesartan medoxomil in the rat monocrotaline model of pulmonary hypertension.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Imidazoles; Lung; Male; Monocrotaline; Olmesartan Medoxomil; Pulmonary Artery; Rats; Rats, Wistar; Tetrazoles; Time Factors | 2008 |
Cilostazol therapy attenuates monocrotaline-induced pulmonary arterial hypertension in rat model.
Topics: Animals; Blood Pressure; Body Weight; Cilostazol; Connexin 43; Disease Models, Animal; Endothelium, Vascular; Gene Expression; Hypertension, Pulmonary; Male; Monocrotaline; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Tetrazoles; Vasodilator Agents | 2008 |
Pulmonary hypertension and ECG changes from monocrotaline pyrrole in the rat.
Topics: Animals; Blood Cell Count; Body Weight; Cardiomegaly; Electrocardiography; Heart; Heart Ventricles; Hypertension, Pulmonary; Kinetics; Lung; Male; Monocrotaline; Organ Size; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains | 1983 |
Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
Topics: Animals; Body Weight; Cardiomegaly; Dexamethasone; Heart Diseases; Hydralazine; L-Lactate Dehydrogenase; Lung; Lung Diseases; Monocrotaline; Myocardium; Organ Size; Pyrrolizidine Alkaloids; Rats; Sulfinpyrazone | 1984 |
Monocrotaline-induced pulmonary endothelial dysfunction in rats.
Topics: Animals; Body Weight; Endothelium; Epoprostenol; Lung; Lung Injury; Male; Microscopy, Electron; Monocrotaline; Organ Size; Peptidyl-Dipeptidase A; Plasminogen Activators; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains | 1984 |
Evaluation of amino acids, B vitamins and butylated hydroxyanisole as protective agents against pyrrolizidine alkaloid toxicity in rats.
Topics: Amino Acids; Animal Feed; Animals; Anisoles; Body Weight; Butylated Hydroxyanisole; Cysteine; Folic Acid; Food, Fortified; Male; Monocrotaline; Plant Poisoning; Plants, Toxic; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Rodent Diseases; Senecio; Vitamin B 12; Vitamin B Complex | 1984 |
Aflatoxin B1 and Crotalaria toxicity in turkey poults.
Topics: Aflatoxin B1; Aflatoxins; Animals; Blood Proteins; Body Weight; Carcinogens; Kidney; Liver; Male; Monocrotaline; Pyrrolizidine Alkaloids; Turkeys | 1984 |
Pneumotoxicity and thrombocytopenia after single injection of monocrotaline.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Platelet Disorders; Body Weight; Cardiomegaly; Dose-Response Relationship, Drug; Lung; Male; Monocrotaline; Perfusion; Plants, Toxic; Platelet Count; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Senecio | 1982 |
Neoplasia and chronic disease associated with the prolonged administration of dehydroheliotridine to rats.
Topics: Age Factors; Animals; Body Weight; Injections, Intraperitoneal; Liver; Lung; Monocrotaline; Neoplasms, Experimental; Pyrrolizidine Alkaloids; Rats; Thioacetamide | 1983 |
Effects of thrombocytopenia on monocrotaline pyrrole-induced pulmonary hypertension.
Topics: Animals; Blood Platelets; Body Weight; Hypertension, Pulmonary; Immune Sera; Lung; Male; Monocrotaline; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Thrombocytosis | 1984 |
Ultrastructure of rat pulmonary arterioles after neonatal exposure to hypoxia and subsequent relief and treatment with monocrotaline.
Topics: Altitude; Animals; Animals, Newborn; Arterioles; Body Weight; Female; Heart Ventricles; Hypoxia; Lung; Male; Microscopy, Electron; Monocrotaline; Organ Size; Rats; Rats, Wistar; Vasoconstrictor Agents | 1995 |
Capsaicin pretreatment attenuates monocrotaline-induced ventilatory dysfunction and pulmonary hypertension.
Topics: Animals; Blood Pressure; Body Weight; Capsaicin; Cardiomegaly; Endopeptidases; Hypertension, Pulmonary; Monocrotaline; Nerve Fibers; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Respiratory Function Tests; Respiratory Tract Diseases; Substance P | 1993 |
Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats.
Topics: Animals; Behavior, Animal; Body Weight; Drug Implants; Estradiol; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Myocardium; Organ Size; Pulmonary Artery; Pulmonary Circulation; Pulmonary Edema; Rats; Rats, Sprague-Dawley | 1993 |
Dietary restriction, polyamines and monocrotaline-induced pulmonary hypertension.
Topics: Animals; Body Weight; DNA; Energy Intake; Heart Ventricles; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Organ Size; Ornithine Decarboxylase; Polyamines; Rats; Rats, Sprague-Dawley | 1993 |
The effect of nifedipine on monocrotaline-induced pulmonary hypertension in rats.
Topics: Acute Disease; Animals; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy; Injections, Intraperitoneal; Monocrotaline; Nifedipine; Organ Size; Pulmonary Artery; Random Allocation; Rats; Rats, Sprague-Dawley | 1993 |
COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
Topics: Animals; Body Weight; Cysteine; Glutathione; Lung; Male; Monocrotaline; Pulmonary Heart Disease; Rats; Rats, Sprague-Dawley | 1993 |
Effects of taurine and guanidinoethane sulfonate on toxicity of the pyrrolizidine alkaloid monocrotaline.
Topics: Amino Acids; Animals; Body Weight; Cysteine; Glutathione; Liver; Male; Monocrotaline; Organ Size; Rats; Rats, Sprague-Dawley; Taurine | 1996 |
Semotiadil improves survival of rats with monocrotaline-induced pulmonary hypertension: comparison with diltiazem.
Topics: Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Heart; Hypertension, Pulmonary; Male; Monocrotaline; Rats; Rats, Wistar; Thiazoles | 1996 |
Growth factor expression and effects of amrinone in monocrotaline-induced pulmonary hypertension in rats.
Topics: Amrinone; Animals; Body Weight; Bronchi; Cardiotonic Agents; Fibroblast Growth Factor 2; Hypertension, Pulmonary; Immunohistochemistry; Lung; Male; Monocrotaline; Myocardium; Organ Size; Phosphodiesterase Inhibitors; Platelet-Derived Growth Factor; Poisons; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1996 |
Aorta and skeletal muscle NO synthase expression in experimental heart failure.
Topics: Animals; Aorta; Ascites; Body Weight; Endothelium, Vascular; Female; Heart Failure; Monocrotaline; Muscle, Skeletal; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Organ Size; Pleural Effusion; Rats; Rats, Sprague-Dawley | 1996 |
Hemodynamic and inotropic effects of nitric oxide in pulmonary hypertension.
Topics: Animals; Body Weight; Disease Models, Animal; Dogs; Hemodynamics; Hypertension, Pulmonary; Monocrotaline; Myocardial Contraction; Nitric Oxide; Pulmonary Circulation; Regional Blood Flow; Vascular Resistance | 1997 |
Cardiac and vascular responses after monocrotaline-induced hypertrophy in rats.
Topics: Animals; Body Weight; Disease Models, Animal; Heart; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Myocardial Contraction; Poisons; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Stimulation, Chemical; Vasoconstriction | 1998 |
Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy.
Topics: Animals; Body Weight; Cardiomyopathy, Dilated; Electrophoresis, Polyacrylamide Gel; Monocrotaline; Muscle, Skeletal; Myosin Heavy Chains; Rats; Rats, Sprague-Dawley; Regional Blood Flow | 1998 |
Improvement of mortality by long-term E4010 treatment in monocrotaline-induced pulmonary hypertensive rats.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Atrial Natriuretic Factor; Body Weight; Calcium Signaling; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Hypertension, Pulmonary; Ligands; Male; Monocrotaline; Nitric Oxide; Nitriles; Organ Size; Phosphodiesterase Inhibitors; Piperidines; Rats; Rats, Wistar; Survival Rate | 1999 |
Impaired endothelium-dependent relaxation by adrenomedullin in monocrotaline-treated rat arteries.
Topics: Acetylcholine; Adrenomedullin; Animals; Aorta, Thoracic; Body Weight; Endothelium, Vascular; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; In Vitro Techniques; Male; Monocrotaline; Organ Size; Peptides; Pulmonary Artery; Rats; Rats, Wistar; Time Factors; Vasodilation; Vasodilator Agents | 1999 |
Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats.
Topics: Animals; Body Weight; Calcium; Carbachol; Cyclic GMP; Endothelium, Vascular; Hypertension, Pulmonary; In Vitro Techniques; Male; Monocrotaline; Muscarinic Agonists; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Organ Size; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 1999 |
Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure.
Topics: Animals; Apoptosis; Atrophy; Blotting, Western; Body Weight; Caspase 3; Caspases; Cell Nucleus; Chronic Disease; Heart Failure; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; In Situ Nick-End Labeling; Male; Monocrotaline; Muscle Fibers, Slow-Twitch; Muscle, Skeletal; Myosin Heavy Chains; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Ubiquitins | 1999 |
The cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in monocrotaline-treated rats.
Topics: Adenylyl Cyclases; Animals; Blood Pressure; Blotting, Western; Body Weight; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; GTP-Binding Proteins; Humans; Kinetics; Male; Monocrotaline; Myocardium; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Muscarinic; Time Factors | 2000 |
Reactive oxygen species and substance P in monocrotaline-induced pulmonary hypertension.
Topics: Animals; Body Weight; Carbon; Free Radical Scavengers; Hematocrit; Hypertension, Pulmonary; Immunoenzyme Techniques; Luminescent Measurements; Male; Monocrotaline; Muscle, Smooth, Vascular; Poisons; Pulmonary Artery; Pulmonary Circulation; Rats; Rats, Wistar; Reactive Oxygen Species; Substance P; Thiourea | 2001 |
Lack of protective action of cysteine against the fetotoxic effect of monocrotaline.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Creatinine; Cysteine; Eating; Female; Fetal Death; Fetus; Male; Monocrotaline; Organ Size; Plant Extracts; Poisoning; Pregnancy; Rats; Rats, Wistar; Treatment Failure; Urea | 2001 |
Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Body Weight; Hypertension, Pulmonary; Imidazoles; Losartan; Male; Monocrotaline; Pressoreceptors; Rats; Rats, Inbred Strains; Renin; Tetrazoles | 1992 |
An evaluation of procoagulant activity in the peripheral blood of rats treated with monocrotaline pyrrole.
Topics: Animals; Blood Coagulation; Body Weight; Bronchoalveolar Lavage Fluid; Cardiomegaly; Injections, Intravenous; Lung; Male; Monocrotaline; Organ Size; Partial Thromboplastin Time; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains | 1991 |
Early indications of monocrotaline pyrrole-induced lung injury in rats.
Topics: Animals; Body Weight; Bronchoalveolar Lavage Fluid; L-Lactate Dehydrogenase; Lung; Male; Monocrotaline; Organ Size; Proteins; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Time Factors | 1991 |
Immunotoxicity of the pyrrolizidine alkaloid monocrotaline following subchronic administration to C57Bl/6 mice.
Topics: Animals; Antibodies; Body Weight; Dose-Response Relationship, Drug; Erythrocytes; Female; Immunization; Immunocompetence; Leukocyte Count; Liver; Lung; Mice; Mice, Inbred Strains; Monocrotaline; Organ Size; Pyrrolizidine Alkaloids; Random Allocation; Spleen; Viral Plaque Assay | 1990 |
Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
Topics: Animals; Biomarkers; Body Weight; Bronchoalveolar Lavage Fluid; Dimethylformamide; Hemodynamics; Hypertension, Pulmonary; Injections, Intravenous; L-Lactate Dehydrogenase; Lung; Male; Monocrotaline; Organ Size; Proteins; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Time Factors | 1990 |
Alteration of fate of vasoactive autacoids in pulmonary circulation following monocrotaline-induced lung vascular injury in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Autacoids; Blood Pressure; Body Weight; Bradykinin; Dinoprostone; Injections, Subcutaneous; Lung; Lung Diseases; Male; Monocrotaline; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Substance P; Time Factors | 1988 |
Polyamine synthesis blockade in monocrotaline-induced pneumotoxicity.
Topics: Animals; Biogenic Polyamines; Body Weight; Eflornithine; Heart; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Organ Size; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains | 1989 |
Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats.
Topics: Animals; Blood Platelets; Body Weight; Dimethylformamide; Hemoglobins; Hypertension, Pulmonary; Indium Radioisotopes; Injections, Intravenous; Lung; Male; Monocrotaline; Platelet Count; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Splenectomy | 1989 |
The effect of dietary restriction and altered sodium intake on the cardiopulmonary toxicity of monocrotaline pyrrole.
Topics: Animals; Biotransformation; Body Weight; Cardiomegaly; Diet; Diet, Sodium-Restricted; L-Lactate Dehydrogenase; Lung Diseases; Male; Monocrotaline; Organ Size; Proteins; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Sodium | 1985 |
Monocrotaline-induced pulmonary fibrosis in rats: amelioration by captopril and penicillamine.
Topics: Animals; Body Weight; Captopril; Hydroxyproline; Lung; Male; Monocrotaline; Organ Size; Penicillamine; Peptidyl-Dipeptidase A; Plants, Toxic; Proline; Pulmonary Fibrosis; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Senecio | 1985 |
Monocrotaline-induced cardiopulmonary damage in rats: amelioration by the angiotensin-converting enzyme inhibitor CL242817.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arterial Occlusive Diseases; Body Weight; Heart; Hydroxyproline; Hypertension; Lung; Male; Monocrotaline; Organ Size; Peptidyl-Dipeptidase A; Plasminogen Activators; Proline; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains | 1986 |
Monocrotaline-induced cardiopulmonary injury in rats: modification by thiol and nonthiol ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cardiomegaly; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Organ Size; Peptidyl-Dipeptidase A; Pyrrolizidine Alkaloids; Rats; Sulfhydryl Compounds | 1987 |
Effect of 2(3)-tert-butyl-4-hydroxyanisole (BHA) and 2-chloroethanol against pyrrole production and chronic toxicity of monocrotaline in chickens.
Topics: Animals; Body Weight; Butylated Hydroxyanisole; Chickens; Chlorohydrins; Ethylene Chlorohydrin; Female; Liver; Male; Monocrotaline; Organ Size; Pyrroles; Pyrrolizidine Alkaloids | 1987 |
6-keto prostaglandin F1 alpha and thromboxane B2 in isolated, buffer-perfused lungs from monocrotaline pyrrole-treated rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Body Weight; Hydrostatic Pressure; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Organ Size; Perfusion; Pyrrolizidine Alkaloids; Rats; Thromboxane B2; Time Factors | 1987 |
Pulmonary vascular responses induced by the pyrrolizidine alkaloid, monocrotaline, in rats.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Hypertension, Pulmonary; Male; Monocrotaline; Norepinephrine; Organ Size; Pulmonary Circulation; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Serotonin; Vasoconstriction | 1987 |
Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension.
Topics: Animals; Blood Pressure; Body Weight; Carbon Dioxide; Endothelium, Vascular; Heart Ventricles; Hematocrit; Hypertension, Pulmonary; Male; Monocrotaline; Organ Size; Oxygen; Partial Pressure; Plants, Toxic; Pulmonary Artery; Pulmonary Circulation; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Senecio; Vascular Resistance | 1988 |
Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
Topics: Animals; Body Weight; Cardiomegaly; Heart Ventricles; Hypertension, Pulmonary; Male; Methylprednisolone; Monocrotaline; Pulmonary Heart Disease; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains | 1985 |
The effect of immunosuppressants and adoptive transfer in monocrotaline pyrrole pneumotoxicity.
Topics: Animals; Antilymphocyte Serum; Body Weight; Bronchoalveolar Lavage Fluid; Cyclosporins; Disease Models, Animal; Hypertension, Pulmonary; Hypertrophy; Immunization, Passive; Immunosuppressive Agents; L-Lactate Dehydrogenase; Lung; Lymphocytes; Male; Monocrotaline; Organ Size; Pyrrolizidine Alkaloids; Rats; Rats, Inbred F344; Rats, Inbred Strains | 1987 |